We found that lncRNA-MIR22HG and RCC1 were presented with some genes that known to cause tumorigenesis, cancer progression and resistance in other cancer systems [20–23], suggesting that these two lncRNAs interact with genes that necessary for drug resistance in lung cancer. This evidence concerns the gene MIR22HG and lung cancer.